Advertisement.

TARA Projected Dividend Yield

Protara Therapeutics Inc ( NASDAQ : TARA )

Protara Therapeutics is a clinical-stage biopharmaceutical company focused on identifying and developing transformative therapies for the treatment of cancer and rare diseases. Co.'s primary oncology program is TARA-002 in non-muscle invasive bladder cancer. Co. is also pursuing TARA-002 in lymphatic malformations, which are rare, non-malignant cysts of the lymphatic vascular system. The third development program in Co.'s portfolio is intravenous Choline Chloride, an investigational phospholipid substrate replacement therapy initially in development for patients receiving parenteral nutrition, who have intestinal failure associated liver disease.

21 YEAR PERFORMANCE RESULTS

TARA Dividend History Detail
TARA Dividend News
TARA Competitors News

# of Shares: 0

Closing Price: 6.14

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000